当前位置: X-MOL 学术Nature › 论文详情
Integrating genomic features for non-invasive early lung cancer detection
Nature ( IF 43.070 ) Pub Date : 2020-03-25 , DOI: 10.1038/s41586-020-2140-0
Jacob J. Chabon; Emily G. Hamilton; David M. Kurtz; Mohammad S. Esfahani; Everett J. Moding; Henning Stehr; Joseph Schroers-Martin; Barzin Y. Nabet; Binbin Chen; Aadel A. Chaudhuri; Chih Long Liu; Angela B. Hui; Michael C. Jin; Tej D. Azad; Diego Almanza; Young-Jun Jeon; Monica C. Nesselbush; Lyron Co Ting Keh; Rene F. Bonilla; Christopher H. Yoo; Ryan B. Ko; Emily L. Chen; David J. Merriott; Pierre P. Massion; Aaron S. Mansfield; Jin Jen; Hong Z. Ren; Steven H. Lin; Christina L. Costantino; Risa Burr; Robert Tibshirani; Sanjiv S. Gambhir; Gerald J. Berry; Kristin C. Jensen; Robert B. West; Joel W. Neal; Heather A. Wakelee; Billy W. Loo; Christian A. Kunder; Ann N. Leung; Natalie S. Lui; Mark F. Berry; Joseph B. Shrager; Viswam S. Nair; Daniel A. Haber; Lecia V. Sequist; Ash A. Alizadeh; Maximilian Diehn

Radiologic screening of high-risk adults reduces lung-cancer-related mortality1,2; however, a small minority of eligible individuals undergo such screening in the United States3,4. The availability of blood-based tests could increase screening uptake. Here we introduce improvements to cancer personalized profiling by deep sequencing (CAPP-Seq)5, a method for the analysis of circulating tumour DNA (ctDNA), to better facilitate screening applications. We show that, although levels are very low in early-stage lung cancers, ctDNA is present prior to treatment in most patients and its presence is strongly prognostic. We also find that the majority of somatic mutations in the cell-free DNA (cfDNA) of patients with lung cancer and of risk-matched controls reflect clonal haematopoiesis and are non-recurrent. Compared with tumour-derived mutations, clonal haematopoiesis mutations occur on longer cfDNA fragments and lack mutational signatures that are associated with tobacco smoking. Integrating these findings with other molecular features, we develop and prospectively validate a machine-learning method termed ‘lung cancer likelihood in plasma’ (Lung-CLiP), which can robustly discriminate early-stage lung cancer patients from risk-matched controls. This approach achieves performance similar to that of tumour-informed ctDNA detection and enables tuning of assay specificity in order to facilitate distinct clinical applications. Our findings establish the potential of cfDNA for lung cancer screening and highlight the importance of risk-matching cases and controls in cfDNA-based screening studies.
更新日期:2020-03-26

 

全部期刊列表>>
宅家赢大奖
向世界展示您的会议墙报和演示文稿
全球疫情及响应:BMC Medicine专题征稿
新版X-MOL期刊搜索和高级搜索功能介绍
化学材料学全球高引用
ACS材料视界
x-mol收录
自然科研论文编辑服务
南方科技大学
南方科技大学
西湖大学
中国科学院长春应化所于聪-4-8
复旦大学
课题组网站
X-MOL
香港大学化学系刘俊治
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug